🇺🇸 SRPT — Sarepta Therapeutics, Inc.
Salud MantenerPrecio actual
17,82 USD
Máx. histórico
178,74
2145 días
Split 1:6 del 12/07/2012
Caída desde máximo
-90,03%
Rango 52 semanas
14,68 – 24,68
Variación hoy
+1,42%
Cierre anterior
17,57
Rango de hoy
17,52 – 18,77
Volumen hoy
2.596.193
Peor caída histórica
-98,17%
09/02/2000 → 18/12/2008
Recuperado en 3568 días
Volatilidad anualizada ⓘ
95,43%
- Nombre completo
- Sarepta Therapeutics, Inc.
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 835
- PER ⓘ
- —
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 21,64 USD (puede no estar actualizado)
- Primera cotización
- 04/06/1997
- Precio actualizado
- hace 12 horas
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.
| Fecha | Ratio |
|---|---|
| 12/07/2012 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 21/02/2018 | 64,00 | 65,11 | 63,17 | 63,22 | +0,56% | 3,03% | 931.600 |
| 20/02/2018 | 64,25 | 64,78 | 62,42 | 62,87 | -1,77% | 3,67% | 1.288.000 |
| 16/02/2018 | 62,72 | 64,49 | 62,01 | 64,00 | +1,36% | 3,95% | 1.836.400 |
| 15/02/2018 | 60,00 | 63,69 | 59,13 | 63,14 | +5,99% | 7,60% | 1.802.400 |
| 14/02/2018 | 58,51 | 60,16 | 58,02 | 59,57 | +1,19% | 3,66% | 1.251.800 |
| 13/02/2018 | 59,00 | 59,49 | 57,43 | 58,87 | +0,53% | 3,49% | 757.400 |
| 12/02/2018 | 56,06 | 59,14 | 56,00 | 58,56 | +6,20% | 5,60% | 1.499.700 |
| 09/02/2018 | 55,33 | 56,36 | 50,68 | 55,14 | -3,55% | 10,27% | 4.586.200 |
| 08/02/2018 | 61,37 | 61,37 | 57,13 | 57,17 | -6,20% | 6,91% | 1.163.700 |
| 07/02/2018 | 61,91 | 63,00 | 60,76 | 60,95 | -2,15% | 3,62% | 860.800 |
| 06/02/2018 | 58,97 | 62,59 | 57,30 | 62,29 | +2,79% | 8,97% | 1.541.700 |
| 05/02/2018 | 62,50 | 64,42 | 60,48 | 60,60 | -3,99% | 6,30% | 1.736.500 |
| 02/02/2018 | 64,76 | 65,52 | 62,91 | 63,12 | -3,04% | 4,03% | 1.079.600 |
| 01/02/2018 | 65,35 | 66,55 | 64,46 | 65,10 | -0,67% | 3,20% | 850.100 |
| 31/01/2018 | 64,85 | 66,92 | 64,85 | 65,54 | +1,22% | 3,19% | 1.036.500 |
| 30/01/2018 | 66,90 | 67,80 | 64,47 | 64,75 | -4,70% | 4,98% | 1.846.800 |
| 29/01/2018 | 67,37 | 68,70 | 67,17 | 67,94 | +0,53% | 2,27% | 1.078.900 |
| 26/01/2018 | 67,84 | 68,90 | 67,12 | 67,58 | -0,04% | 2,62% | 1.296.300 |
| 25/01/2018 | 66,55 | 68,67 | 65,44 | 67,61 | +2,78% | 4,85% | 1.940.000 |
| 24/01/2018 | 66,76 | 67,19 | 64,55 | 65,78 | -1,85% | 3,95% | 1.752.100 |
| 23/01/2018 | 65,32 | 67,74 | 65,10 | 67,02 | +2,09% | 4,04% | 1.825.500 |
| 22/01/2018 | 63,09 | 66,08 | 63,01 | 65,65 | +5,24% | 4,87% | 2.351.700 |
| 19/01/2018 | 61,90 | 62,64 | 61,37 | 62,38 | +0,87% | 2,05% | 1.227.500 |
| 18/01/2018 | 61,31 | 62,96 | 60,60 | 61,84 | +1,10% | 3,85% | 1.504.900 |
| 17/01/2018 | 60,32 | 61,69 | 60,10 | 61,17 | +1,70% | 2,64% | 1.198.600 |
| 16/01/2018 | 61,65 | 62,85 | 59,26 | 60,15 | -2,23% | 5,82% | 2.035.100 |
| 12/01/2018 | 58,66 | 61,89 | 58,63 | 61,52 | +4,29% | 5,56% | 2.218.300 |
| 11/01/2018 | 59,16 | 60,22 | 57,66 | 58,99 | -0,25% | 4,33% | 1.633.800 |
| 10/01/2018 | 56,00 | 59,50 | 55,86 | 59,14 | +5,33% | 6,50% | 2.185.900 |
| 09/01/2018 | 53,87 | 56,75 | 53,17 | 56,15 | +3,94% | 6,65% | 2.309.800 |